Noopur S. Raje, MD, and Kenneth C. Anderson, MD, on Myeloma Bone: Updated Results on Anti-BCMA CAR T-Cell Therapy

Posted: Tuesday, August 15, 2017

Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, and Noopur S. Raje, MD, of the Massachusetts General Hospital Cancer Center, discuss new findings from the first-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma.